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PDGF-A Signaling Is a Critical Event
in Lung Alveolar Myofibroblast Development
and Alveogenesis
Hans BostroÈ m,1, 6 Karen Willetts, 3, 4, 6 Milos Pekny,1 PDGF receptor a (PDGFRa) and PDGFRb. The current
model of PDGF ligand±receptor interaction postulatesPer LeveÂ en,1 Per Lindahl,1 HaÊ kan Hedstrand,1, 7
the B chain as a universal ligand (i.e., binding both aMarcela Pekna,1 Mats HellstroÈ m,1
and b receptors) and the a receptor as a universal recep-Samuel Gebre-Medhin,1 Martin Schalling,5
tor (i.e., binding both A and B chains) (reviewed by Hel-Mia Nilsson,5 Siri Kurland,1, 8 Jan ToÈ rnell,2
din, 1992). PDGF is mitogenic in vitro for a wide varietyJohn K. Heath,3 and Christer Betsholtz1
of cell types, but its in vivo functions are poorly under-1Department of Medical Biochemistry
stood. PDGF-A, PDGFRa, and PDGFRb exhibit wide-2Department of Physiology
spread expression in the developing embryo (RappoleeUniversity of GoÈ teborg
et al., 1988; Mercola et al., 1990; Holmgren et al., 1991;S-413 90 GoÈ teborg
Morrison-Graham et al., 1992; Orr-Urtreger et al., 1992;Sweden
Orr-Urtreger and Lonai, 1992; Palmieri et al., 1992;3School of Biochemistry
Schatteman et al., 1992; Shinbrot et al., 1994), whichUniversity of Birmingham
has been argued to indicate multiple functions for PDGFEdgbaston B15 2TT
in prenatal development of mesenchymal structures.United Kingdom
patch mutant mice, which are homozygous for a large4Department of Biochemistry
deletion encompassing the PDGFRa locus, die at earlyUniversity of Oxford
postimplantation to mid-gestational stages, displayingOxford OX1 3QU
generalized deficiencies in mesenchymal tissues (GruÈ -United Kingdom
neberg and Truslove, 1960; Morrison-Graham et al.,5Neurogenetics Unit
1992; Orr-Urtreger et al., 1992; Schatteman et al., 1992).Department of Molecular Medicine
Although the defective tissues in patch homozygotesKarolinska Hospital
normally express PDGFRa, it is possible that part of theS-171 76 Stockholm
patch phenotype reflects the loss, or misexpression, ofSweden
other genes, such as c-kit (Duttlinger et al., 1995).
Some studies have attempted to address experimen-
tally the PDGF physiology using loss-of-function ap-Summary
proaches in vivo. The effects of the expression of a
potent dominant-negative PDGF receptor mutant inA mouse platelet-derived growth factor A chain
Xenopus embryos perturbed gastrulation (Ataliotis et(PDGF-A) null allele is shown to be homozygous lethal,
al., 1995). We (LeveÂ en et al., 1994) and Soriano (1994)with two distinct restriction points, one prenatally be-
have previously generated mice deficient for PDGF-Bfore E10 and one postnatally. Postnatally surviving
and PDGFRb, respectively. Such mice develop normallyPDGF-A-deficient mice develop lung emphysema sec-
until late gestation, at which time similar phenotypesondary to the failure of alveolar septation. This is ap-
occur in the two mutants, involving cardiovascular, he-parently caused by the loss of alveolar myofibroblasts
matological, and renal abnormalities. In particular, aand associated elastin fiber deposits. PDGF a recep-
complete absence of mesangial cells in the kidney glo-tor±positive cells in the lung having the location of
merulus was seen (LeveÂ en et al., 1994; Soriano, 1994).
putative alveolar myofibroblast progenitors were spe-
We now report on the generation and phenotypic char-
cifically absent in PDGF-A null mutants. We conclude
acterization of mice deficient for PDGF-A. These mice
that PDGF-A is crucial for alveolar myofibroblast on-
lack PDGF-AA and PDGF-AB, but retain the capacity to
togeny. We have previously shown that PDGF-B is re- produce PDGF-BB. Their phenotype reveals a role for
quired in the ontogeny of kidney mesangial cells. The
PDGF-A in early embryonic development, as well as a
PDGFs therefore appear to regulate the generation of
specific role for PDGF-A in lung alveolar myofibroblast
specific populations of myofibroblasts during mam-
ontogeny and alveogenesis.
malian development. The two PDGF null phenotypes
also reveal analogous morphogenetic functions for Results
myofibroblast-type cells in lung and kidney organo-
genesis. Production of PDGF-A Null Mice
A PDGF-A targeting vector (Figure 1A) was created in
Introduction which the exon 4 of the PDGF-A gene was replaced
by a PGK±neo cassette. Approximately 10% of stably
Platelet-derived growth factors (PDGFs) are dimers of transfected embryonic stem (ES) cell clones scored pos-
A or B chains (or both) that exert their functions by itive for targeting at the PDGF-A locus (Figure 1B). Two
interacting with two related receptor tyrosine kinases, of these were used to derive germline chimeras and
mice heterozygous and homozygous for the PDGF-A
mutant allele (Figure 1C). Exon 4±specific hybridization6These authors contributed equally to the present work.
was lost in homozygous DNA and was reduced in het-7 Present address: Department of Internal Medicine, Uppsala Aca-
erozygous DNA, demonstrating that the expected dele-demic Hospital, S-751 85 Uppsala, Sweden.
8 Present address: GaÈ vle Hospital, S-801 87 GaÈ vle, Sweden. tion had occurred in the PDGF-A mutant allele (Figure
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Figure 1. Targeting of the PDGF-A Locus
(A) Restriction maps of the mouse PDGF-A
locus and the targeting construct. The probe
used for screening for homologous recombi-
nation is indicated, and the screening strat-
egy is outlined.
(B and C) Southern blot analysis of ES cell
(B) and mouse tail (C) DNA from two litters
born from heterozygous parents. A mutant
individual is indicated (arrowhead).
(D) Southern blot analysis of 1/1, 1/2, and
2/2 DNA from mutant lines 29 and 33. Here,
the DNA was digested with a combination of
EcoRI and BamHI, and the blot was probed
with the 2.5 kb EcoRI±BamHI fragment en-
compassing exon 4. The lack of a hybridizing
2.5 kb band in the 2/2 DNAs implies that
the targeting construct was integrated by a
replacement mechanism in both mutant lines.
(E) Schematic illustration of the PDGF-A null
phenotypes in 129Sv/C57Bl hybrid genetic
background. Of null embryos, 50% die before
E10. At E17±E19, all surviving null embryos
are growth retarded. Another 30% of the null
individuals die early postnatally, and the re-
maining ones live for an average of 3±4 weeks
and develop lung emphysema.
(F) The weight of newborn pups from hetero-
zygous crossings of PDGF-A mutant line 29.
The graph illustrates the following data: wild
type/wild type (Wt/Wt; n 5 36), 1.564 g (mean)
and 0.177 g (standard deviation); wild type/
mutant (Wt/Mut; n 5 61), 1.549 g (mean) and
0.172 g (standard deviation); mutant/mutant
(Mut/Mut; n 5 11), 1.108 g (mean) and 0.133
g (standard deviation). Statistical analysis us-
ing the Student's unpaired t test gave the
following significance values: wild type/wild
type versus wild type/mutant, p 5 0.6787
(not significant); wild type/wild type versus
mutant/mutant, p < 0.0001 (significant);
wild type/mutant versus mutant/mutant, p <
0.0001 (significant).
1D). The mutant allele is expected to be fully inactivated as well as wild-type mice as controls for the study of
because exon 4 encodes the N-terminal half of the ma- phenotypes present in the null mice.
ture PDGF A chain, which contains structures crucial
for PDGF bioactivity, including six of the eight cysteine
Breeding Dataresidues (Rorsman et al., 1988; Heldin et al., 1993). Po-
Heterozygous (PDGF-A1/2) mice were kept as 129Sv/tential exon 4 skipping would generate a frameshift, in
C57Bl hybrids. These appear normal and fertile and havewhich the exon 5±encoded C-terminal half of the PDGF
been healthy over the normal mouse life span. Inter-A chain also becomes truncated. However, to control
crossings of heterozygous animals produced wild-type,for any potential dominant feature (e.g., dominant nega-
tive) of the mutant allele, we have used heterozygous heterozygous, and null offspring in the ratios shown in
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Table 1. Numbers and Frequencies of PDGF-A 1/1, 1/2, and Postnatal null mice could easily be distinguished from
2/2 Individuals in Litters of Heterozygous Crosses their littermates by their smaller size (Figure 1F). By 4
weeks, null mice were half the size of littermates or less1/1 1/2 2/2
(Figure 2A). No PDGF-A null mice have yet survivedE10.5 74 (25%) 189 (63%) 37 (12%)
beyond 6 weeks of postnatal age. In the present investi-
E11.5 4 7 3 gation, we have focused our attention on the phenotype
E12.5 4 2 1
of PDGF-A null mice that were recovered for analysisE13.5 6 6 4
after E10.E14.5 22 66 19
E15.5 15 40 16
E16.5 7 40 6 Lung Emphysema in PDGF-A Null Mice
E17.5 10 18 6 Dissections of postnatal PDGF-A null mice older than 2
E18.5 74 142 28 weeks revealed symmetrical reduction in the size of
Sum of E11.5±E18.5 142 (26%) 321 (59%) 83 (15%) most organs, which appeared otherwise without obvi-
ous pathological signs. The lungs were clearly diseased,P1±P2 35 (30%) 70 (60%) 12 (10%)
P4 and older 109 (34%) 193 (60%) 20 (6%) however, being hyperinflated and displaying abnormally
large, air-filled cavities throughout the parenchyma (Fig-Numbers and frequencies of embryos and pups with wild-type (1/
ures 2B and 2C). Tissue sections showed a picture of1), heterozygous (1/2), or null (2/2) genotypes, derived from
generalized lung emphysema; alveolar septa, and con-crosses of heterozygous (1/2) parents. Data are pooled from stud-
ies of two separate breeding colonies. The observed distributions sequently alveoli, were nonexistent (Figures 2D and 2E).
atE10.5 andE11.5±E18.5 both significantly differ from theMendelian Histological examination of null hearts revealed a hyper-
1:2:1 ratio (Chi-square test, p , 0.001). The distributions at E10.5 trophic right ventricle with a more than doubled myocar-
and E11.5±E18.5 are not significantly different, indicating that ap-
dium thickness (Figures 2F and 2G). This is comparableproximately 50% of the PDGF-A null embryos die before E10.5, but
to cor pulmonale seen as a consequence of lung emphy-no subsequent loss of null embryos appears to occur during the
sema in humans (Rubin and Farber, 1988) and suggestsprenatal period.There is additional death of PDGF-A null mice during
the early postnatal period. Null mice surviving P4 live for a maximum that cardiac hypertrophy in mutant mice is a secondary
of 6 weeks. consequence of defective lung function. No phenotypic
abnormalities were noticed in the hearts of embryos or
at early postnatal age (data not shown). It is likely that
Table 1. The outcome of the breeding experiment is the death of the null individuals older than 2 weeks
schematically illustrated in Figure 1E. Approximately is caused by respiratory problems. Upon autopsy, the
50% of the null embryos die before embryonic day 10 hyperinflated lung tissue appeared very fragile, and, dur-
(E10), whereas the other half live throughout the prenatal ing dissections under phosphate-buffered saline, air
period. At late gestation, null embryos were 10%±20% bubbles were frequently observed to leave the pleural
smaller than littermates (data not shown), and approxi- surfaces of the mutant lungs. This points to pneumo-
thorax caused by rupture of lung tissue or bleeding inmately half of these died during the first postnatal days.
Figure 2. Lung and Heart Phenotypes in
PDGF-A Null Mice
(A) Heterozygous (1/2) and PDGF-A null
(2/2) pups at 3 weeks of age.
(B and C) The margins of lung lobes from 1/2
and 2/2 lungs at the same magnification in
the dissection microscope. Note the emphy-
sematous appearance of the 2/2 lung.
(E and F) Histological sections of 1/2 and
2/2 lung tissue. Van Gieson elastin stain is
used.
(G and H) Perpendicular sections through the
right heart ventricle walls of 1/2 and 2/2
individuals. The pericardial and endocardial
surfaces are marked by arrowheads to indi-
cate the difference in right ventricular wall
thickness between heterozygote and null mu-
tant hearts. Van Gieson elastin stain is used.
Scale bars represent 300 mm.
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Figure 3. Alveolar Septation Failure in PDGF-
A Null Mice
The morphology of heterozygous and homo-
zygous mutant lungs of PDGF-A mutant line
29 at various postnatal (P) days is shown. At
P4, prealveolar saccules (pas) are present in
both heterozygous and mutant lungs, and
slender elastin fibersare seen at their margins
(arrowheads in [A] and [B]). From P7, alveolar
morphogenesis is seen in the heterozygotes
(arrowheads in the insets), but not in null
(2/2) lungs. Note the presence of large areas
of atelektasis in mutant lungs at E10 (I) and
E19 (J). The scale bar represents 100 mm.
the lungs (observed during postmortem inspection of of alveogenesis (Figures 3D, 3F, and 3H). The emphyse-
matous appearance increases with age, the tissue septaPDGF-A null lungs in several cases) as two potential
causes of death. enclosing the distal air spaces becoming progressively
thinner. Morphometric estimations suggest that little or
no subcompartmentalization of the null lung paren-Failure of Alveolar Septation
Lung sections were compared between PDGF-A null chyma takes place after P4 (data not shown). Instead,
the prealveolar saccules dilate to form large air-filledand heterozygous littermatesat different embryonic and
postnatal ages. Embryonic lungs were histologically in- cavities. Large areas of collapsed lung tissue (atelek-
tasis) were seen in the null lungs from P14 (Figuresdistinguishable for the different genotypes (data not
shown). At postnatal day 4 (P4), prealveolar saccules, 3I and 3J), and smaller areas of atelektasis were seen
already at P4 (data not shown). In older lungs (P19),but not alveoli, have formed in both heterozygous and
null lungs (Figures3A and 3B). At P10±P14, alveogenesis atelektasis oftenaffected whole lung lobes, forcing addi-
tional distension of the remaining air-filled lobes. Fromhas started in the heterozygous lungs; alveolar septa
grow out from the prealveolar saccules (Figures 3C and the combination of progressing emphysema, atelek-
tasis, and thoracic cavity enlargement of the growing3E), and at P19 adult lung histology is essentially ob-
tained (Figure 3G). In the null lungs, there are no signs animal, the lungs would be expected to expand until the
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Figure 4. Loss of Alveolar Myofibroblasts and Elastin in PDGF-A-Deficient Lungs
Histological lung sections are shown from 3-week-old PDGF-A mutant strain 29 1/2 (A, C, and E) and 2/2 (B, D, and F) individuals. (A) and
(B) show immunohistochemistry using an a-smooth muscle actin±specific antibody (brown staining), indicating the loss of positively staining
cells in the lung parenchyma (arrowheads). (C)±(F) show elastin staining. Elastin fibers (black, indicated by arrows) are very sparse and
discontinuous in the null (2/2) (D) versus the heterozygous (1/2) (C) parenchyma, but occur at normal abundance in blood vessel (arrows)
and bronchus (arrowheads) walls (E and F). Scale bars represent 50 mm in (A), (B), (E), and (F) and 25 mm in (C) and (D).
tissue breaks, a scenario in close agreement with the et al., 1990). a-Smooth muscle actin stainings revealed
a profound deficiency in alveolar myofibroblasts inclinical observations described.
3-week-old null mice (Figures 4A and 4B). The null lung
parenchyma of this age was also almost completely
Loss of Alveolar Myofibroblasts devoid of elastin fibers (Figures 4C and 4D), which is
and Parenchymal Elastin consistent with a previous suggestion that alveolar sep-
Smooth muscle cells exist at three locations in the lung, tal elastin is deposited by the alveolar myofibroblasts
in vascular and bronchial walls and in alveolar septae. (Noguchi et al., 1989). Tropo-elastin mRNA expression
Septal smooth muscle cells (contractile interstitial cells and elastin fiber formation appeared normal in heterozy-
or alveolar myofibroblasts) (Kapanchi et al., 1974) have gous and null lungs at E18±P4 (data not shown), i.e.,
the morphology of fibroblasts, but can be shown by before the onset of alveolar septal formation. The thin
ultrastructural analysis to contain contractile elements and sparse elastin fibers still present in the 3-week-old
(Adler et al., 1989; Noguchi et al., 1989; SchuÈ rch et al., null lung (Figure 4D, arrows) probably represent elastin
deposited in the parenchyma at late prenatal and early1992). They also express a-smooth muscle actin (Leslie
Cell
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Figure 5. Ultrastructure of Wild-Type and
PDGF-A-Deficient Lungs
Electron micrographs of peripheral lung tis-
sue in wild-type (A) and PDGF-A null (B) lungs
from 3-week-old mice are shown. The pres-
ence of alveoli (a), an alveolar septum (sep),
alveolar capillaries (cap), endothelial cells
(en), alveolar myofibroblasts (myf), type I
pneumocytes (pn-1), type II pneumocytes
(pn-2), and septal elastin deposits (el) is indi-
cated. The clear zone surroundingthe individ-
ual cells in the mutant tissue (B) is indicated
by arrows. Note its extension into the narrow
space between type I pneumocytes and cap-
illaries (arrowheads in [B]).
postnatal age. The absence of septal myofibroblasts Loss of PDGFRa mRNA±Positive Cells
in Late Embryonic Null Lungsand associated bundles of elastin fibers was confirmed
using electron microscopy (Figure 5). These studies also At E14.5, PDGF-A mRNA is strongly and generally ex-
pressed in the lung epithelium (Figure 6A), whereasrevealed a general morphological difference of the inter-
cellular substance in the mutants, shown as a ªclear PDGFRa mRNA is expressed in the lung mesenchyme
(Figure 6B). The strongest PDGFRa mRNA expressionzoneº surrounding essentially all cells (Figure 5B,
arrows). This zone extends into the narrow space be- appears in the part of the mesenchyme that is in close
apposition to the epithelium (Figure 6B, arrows). A simi-tween the type I pneumocyte and capillary endothelial
cell cytoplasm (Figure 5B, arrowheads). This space has lar expression pattern of PDGFRa mRNA is seen inE14.5
null lungs (data not shown). At E18.5, this expressionbeen proposed to contain elastin deposits with support-
ive structural, or barrier, functions similar to the internal pattern is changed; PDGF-A is no longer expressed at
detectable levels (Figure 6C), and the PDGFRa expres-elastic lamina of larger blood vessels (Damiano et al.,
1979). sion appears confined to a population of scattered cells
in the parenchymal mesenchyme, in addition to smoothThe loss of a-smooth muscle actin±staining cells and
elastin fibers in null lungs older than 2 weeks was limited muscle cells in the walls of bronchi and blood vessels
(Figures 6D, 6E, and 6G, arrowheads). This pattern per-to the lung parenchyma. Vascular and bronchial smooth
muscle with accompanying elastin deposition was sists in the early postnatal lung, but has ceased at P14
(data not shown). The PDGF-A null lungs showed spe-clearly seen in the these lungs (Figures 4E and 4F,
arrows), and vascular smooth muscle also appeared cific absence of the scattered cellular PDGFRa staining
at E18.5 (Figures 6F and 6H). Sites of PDGFRa expres-normal in other organs (data not shown). This suggests
an obligatory requirement for PDGF-A in the ontogeny sion such as bronchial and vascular smooth muscle
(Figures 6F and 6H, arrows) and dermis (data not shown)of alveolar myofibroblasts, but not in the ontogeny of
vascular or bronchial smooth muscle cells. appeared unaffected in the null mice. A weak and diffuse
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Figure 6. Expression of PDGF-A and
PDGFRa in the Developing Lung
In situ hybridization indicating by alkaline
phosphatase staining (blue) the expression
of PDGF-A (A and C) and PDGFRa (B and
D±H).
(A and B) E14.5 lung tissue. Note the expres-
sion in (A) of PDGF-A in the lung epithelium
(e) and, in (B), of PDGFRa in the mesenchyme
(m). The strongest PDGFRa expression is
found in the regions in the immediate vicinity
of the epithelium (arrows in [B]).
(C±H) E18.5 lung tissue. PDGF-A expression
is now undetectable. In 1/2 lungs, PDGFRa
expression is found in a population of scat-
tered parenchymal cells with mesenchymal
location (arrowheads in [E] and [G]) and in
blood vessel and bronchus (b) walls. In 2/2
lungs, the scattered expression of PDGFRa
is absent (F and H), but expression in blood
vessel and bronchus walls appears normal.
Scale bar is 50 mm.
parenchymal staining remaining in the null lung mesen- if at all, PDGF-B exerts PDGFRa-mediated signaling in
vivo.chyme (Figures 6F and 6H) is seen also in the control
Here we have approached the biological function of(Figures 6E and 6G) and probably represents staining
PDGF-A in the mouse by targeted gene disruption. Weof lung fibroblasts.
have found that PDGF-A performs a critical and highly
specific function in the developing lung, leading to alve-
Discussion olar myofibroblast differentiation and alveogenesis.
These events were completely blocked in the PDGF-A-
PDGF-A and PDGFRa are both abundantly expressed deficient mice. The compilation of breeding data from
in the developing mouse embryo. In the preimplantation two different mouse colonies also shows the existence
embryo, the ligand±receptor pair is coexpressed, sug- of an earlier bottleneck for the development of PDGF-
gesting an autocrine interaction, whereas following im- A-deficient embryos, leading to the loss of approxi-
plantation the two molecules adopt an appositional ex- mately half of these embryos before E10. Null embryos
pression pattern with a potential for paracrine signaling, that survive E10 develop until birth, displaying a small,
with the ligand expressed in most epithelial structures but significant,symmetrical size reduction at late embry-
and the receptor in the mesenchyme (Orr-Urtreger and onic and early postnatal stages. This is probably suffi-
Lonai, 1992; this study; K. W. et al., unpublished data). cient to explain why there is an increased mortality of
The second ligand for PDGFRa, PDGF-B, is believed null mice at early postnatal age. The mortality at later
postnatal age is related to the development of pro-to be expressed first at mid-gestation or later in the
gressing, generalized lung emphysema.developing mouse embryo (Mercola et al., 1990), but
The existence of several bottlenecks for the develop-more exact details of the early embryonic PDGF-B ex-
pression pattern are lacking. It is unclear to what extent, ment PDGF-deficient embryos implies multiple func-
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force. The idea that elastin deposition is instrumental intions of PDGF-A during development. The loss of 50%
alveolar septal formation has been raised before basedof the PDGF-A null embryos during early embryonic de-
on the time course and topography of elastin depositsvelopment is consistent with the PDGF-A and PDGFRa
during lung development (Emery, 1970; Noguchi et al.,expression patterns at early developmental stages. It
1989). When alveoli are formed from the larger prealveo-is also consistent with previous reports on the patch
lar saccules, an elastin-rich ridge grows from the sac-phenotype (GruÈ neberg and Truslove, 1960; Morrison-
cule wall to become an alveolar septum with bundlesGraham et al., 1992; Orr-Urtreger et al., 1992; Schatte-
of elastic fibers located at its apex (Burri and Weibel,man et al., 1992) as well as the phenotypes of frog and
1977; this study).sea urchin embryos exposed to PDGF receptor blocking
The details of how the alveolar myofibroblast progeni-agents (Ataliotiset al.,1995; Ramachandran et al., 1995).
tors are specified remain to be elucidated. Clearly, thisIn PDGF-A-deficient embryos, blockage versus passage
process is dependent upon the presence of PDGF-A.of the pre-E10 bottleneck may be related to differences
The absence of the scattered population of PDGFRa-in genetic background of the embryo or the mother (or
positive cells suggests that the cell type is missing al-both), since these studies were performed on 129Sv/
ready in the late prenatal null lung or that the cells areC57Bl hybrids. Compensation for embryonic PDGF-A
present but fail to migrate into the correct location. Adeficiency may relate to differences in PDGF-B expres-
third possibility is that the cells are present at the correctsion, in activities of other, non-PDGF signaling systems,
location, but fail to execute differentiated functions in-or in maternal factors, such as placental transfer of
cluding the expression of PDGFRa. Since both the earlyPDGF, litter size, and embryonic position in the uterus.
lung mesenchyme and the later putative alveolar myofi-Although similar breeding data were obtained in our two
broblast progenitors are PDGFRa positive, direct induc-independent mouse colonies, we cannot exclude the
tion by PDGF-A may be proposed. It is possible that onlyinfluence of other environmental factors as well. Studies
the mesenchymal cells that come in close apposition toare forthcoming that attempt to discriminate between
the PDGF-A-producing lung epithelium are committedthese different possibilities, as well as to define further
to further PDGFRa expression and subsequent alveolarthe pre-E10 bottleneck.
myofibroblast differentiation. Alternatively, such cells
may already be committed to alveolar myofibroblast dif-
Ontogeny and Function of Alveolar Myofibroblasts ferentiation but require PDGF-A for their further growth,
The present study focuses on the lung phenotype of migration, survival, or differentiation. In this context, it
postnatal PDGF-A null mice and the specific absence is worth noticing that the mesenchymal cells in closest
in null lungs of alveolar myofibroblasts. Proposed func- apposition to the epithelium display the strongest ex-
tions of the alveolar myofibroblasts must take into ac- pression of PDGFRa mRNA at mid-gestation (Figure 6B).
count their topographical localization in the alveolar It has been shown that during lung development the
septa, in close proximity to septal deposits of elastin. epithelial cells extend cytoplasmic processes that pro-
Thus, it has been suggested that the alveolar myofi- ject through gaps in the basement membranes and
broblasts are the source of septal elastin (Noguchi et come into close contact with interstitial mesenchymal
al., 1989) and that elastin plays a role in alveogenesis cells (Adamson and King, 1985). The extent of these
(Emery, 1970). The origin of the alveolar myofibroblast contacts correlates with the growth status of the lung
is unclear, and the question has been raised whether it is tissue. It is possible that paracrine epithelial±mesenchy-
identical to that of bronchial smooth muscle or whether mal interactions involving epithelially derived PDGF-AA
these cells have, in part, a separate ontogeny (Fukuda and mesenchymally expressed PDGFRa are facilitated
et al., 1983). The phenotype of the PDGF-A null mice through these intimate contacts. Is there any functional
studied here provides answers to several of these ques- relevance for the putative alveolar myofibroblast pro-
tions, as well as substantial information concerning the genitors to continue to express PDGFRa at late gesta-
function of alveolar myofibroblasts. First, the specific tion and in the early postnatal period when the PDGF-A
lack of these cells, but not of bronchial or vascular expression by the lung epithelium is turned off? The
smooth muscle or lung fibroblasts, suggests that these PDGFRa expression may be functionally insignificant at
cell types have, in part, separate ontogeny. Our demon- this timepoint. Alternatively, PDGF-A deposited in the
stration of a scattered subpopulation of PDGFRa-posi- extracellular matrix at earlier timepoints may also be
tive cells in the peripheral lung parenchyma of the late biologically available at later stages. The long splice
gestational mouse embryo, which ismissing in thecorre- version of PDGF-A (Betsholtz et al.,1986; Rorsman et al.,
sponding PDGF-A null embryo, implicates these cells 1988) possesses a cell and extracellular matrix retention
as the precursors of the alveolar myofibroblasts. The sequence that could potentially account for this (OÈ stman
abundance and distribution of these cells corresponds et al., 1991; Raines and Ross, 1992). In addition, alveolar
to the distribution of the mature alveolar myofibroblasts. macrophages have been proposed to be the major
Second, the specific loss of parenchymal elastin fibers source of lung PDGF-A postnatally (Shimokado et al.,
in PDGF-A null mice argues that the alveolar myofi- 1985; Brody and Bonner, 1991). Macrophage-derived
broblasts constitute the major source of such fibers. PDGF-A may thus promote further proliferation, survival,
Third, the lack of alveolar septa in the PDGF-A null lungs or differentiation of the alveolar myofibroblast progeni-
suggests a crucial role for the alveolar myofibroblasts tors at postnatal stages, as well as mediate lung repair
in alveolar septal formation and, consequently, in al- and fibrosis. Finally, capillary endothelial cells in the
veogenesis. The deposition of elastin fibers in the preal- lung, as well as elsewhere in the embryo, have been
shown to express PDGF-B (K. W. et al., unpublishedveolar saccule wall may be the critical morphogenetic
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data). It is possible that capillary endothelium±derived
PDGF-B further stimulates the PDGFRa-positive cells
in the lung, since in their final locations in the alveolar
septum the alveolar myofibroblasts and capillary endo-
thelial cells are in close proximity.
Analogous Functions for PDGFs
and Myofibroblasts
The PDGF-A mutants do not display any of the pheno-
types seen in PDGF-B or PDGFRb-deficient mice; i.e.,
kidney glomeruli appeared morphologically normal both
at prenatal and postnatal stages, there were no signs
of heart or blood vessel pathology (apart from the cor
pulmonale, which is seen in conjunction with advanced
emphysema), there was no apparent hemorrhaging, and
examinations of the blood failed to show anemia, eryth-
roblastosis, and thrombocytopenia, which are all hall-
marks of the PDGF-B or PDGFRb null phenotypes (Lev-
eÂen et al., 1994; Soriano, 1994; data not shown).
However, although they are nonoverlapping, there are
several similarities between the lung phenotype of
PDGF-A null mice described here and the mesangial
cell deficiency of kidney glomeruli in PDGF-B and
PDGFRb null mice. Mesangial cells, like alveolar myofi-
broblasts, express a-smooth muscle actin and have a
contractile phenotype intermediate between those of
smooth muscle cells proper and fibroblasts. In both
Figure 7. Phenotypical Analogies in PDGF Null Micecases of PDGF gene disruption, a myofibroblast-type
Schematic illustration of the kidney glomerulus phenotype in PDGF-cell is affected that appears to act as an ªanchorº for an
B- or PDGFRb-deficent mice and the lung phenotype in PDGF-A-involuted epithelial sheet (Figure 7). Loss of the anchor
deficient mice. Myofibroblasts are depicted in black, epithelial cellsresulting from genetic ablation of PDGF leads to failure
in green, and endothelial cells in yellow. The loss of myofibroblasts
of involution. In both cases, physiological function is leads to the loss of structural complexity and functionally active
impaired as a result of decreased surface area, either surface area for filtration (PDGF-B or PDGFRb deficiency) or respira-
for glomerular filtration (PDGF-B or PDGFRb mutants) tion (PDGF-A deficiency), respectively.
(A) Normal glomerulus.or for gas exchange (PDGF-A mutants). In addition, the
(B) Glomerulus of PDGF-B- or PDGFRb-deficient mice.mechanical properties of the two structures must be
(C) Normal lung alveolar sack.changed as a result of the loss of the specialized extra-
(D) Alveolar sack of PDGF-A mutant mice.
cellular matrix, the mesangial matrix and the septal elas-
tin deposits, respectively. By focal attachment of the
(Betsholtz et al., 1986; Rorsman et al., 1988) and mouse (Rorsmancollagenous mesangial matrix to the glomerular base-
and Betsholtz, 1992) PDGF-A sequences. PGK±neo, a neomycin
ment membrane, the mesangial cells may act as interior phosphotransferase (neo) expression cassette, was used to replace
glomerular ªfilter holders,º the function of which is most the entire fourth exon of the PDGF-A gene along with flanking intron
sequences in a targeting construct including a total of 10 kb oflikely a prerequisite for efficient filtration and drainage
homologous sequence. A genomic probe, flanking the targetingof the filtrate (Betsholtz, 1995). In addition, mesangial
construct by its 59 end, was used to discriminate between the wild-cells are clearly contractile (Schlondorff, 1987), and they
type (11.5 kb) and targeted (10 kb) alleles in Southern blot analyses
are thought to provide modulation of intraglomerular of ES cell, embryo, or tail DNA. (Figure 1). Loss of exon 4 in the
blood flow under physiological conditions. Likewise, mutant allele was confirmed using the EcoRI±BamHI fragment en-
septal elastin does not only seem to be a prerequisite compassing exon 4 (see Figure 1) as a probe in Southern blot hybrid-
izations of EcoRI±BamHI-digested DNA (Figure 1D). Protocols forfor alveolar septum formation and integrity, but also
E14±E1 ES cell culture (Hooper et al., 1987; KuÈ hn et al., 1991),provides elastic properties to the lung parenchyma,
transfection, isolation of G418-resistant clones, DNA analyses, andwhich is of profound importance to respiration mechan-
the derivation of chimeric and, subsequently, mutant mice have
ics. Also, the alveolar myofibroblasts are contractile and been described previously (LeveÂ en et al., 1994). Heterozygous
may be involved in the regulation of alveolar±capillary mouse stocks were maintained as 129Sv/C57BL hybrids.
blood flow and oxygenation (Kapanchi et al., 1974).
Histology and ImmunohistochemistryTaken together, there is a clear analogy regarding the
Mouse tissues were fixed in buffered formalin, paraffin embedded,growth factor dependence and the developmental and
sectioned, and stained according to standard protocols (Smith and
proposed physiological roles for mesangial cells and Bruton, 1978). An a-smooth muscle actin antibody (clone 1A4; Dako)
alveolar myofibroblasts. was used in immunohistochemistry according to protocols supplied
by the manufacturer.
Experimental Procedures
Electron Microscopy
Production of PDGF-A Mutant Mice Lung specimen were fixed overnight at 48C in 3% glutaraldehyde
Mouse genomic PDGF-A clones were isolated from a 129Sv library in 0.1 M cacodylate buffer (pH 7.2) and postfixed at room tempera-
ture in 1% osmium tetroxide in 0.1 M cacodylate buffer. After fixa-(Stratagene 946306) and characterized by comparison with human
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tion, the specimen were rinsed in buffer, stained with 1% uranyl
acetate in 50% ethanol overnight, dehydrated in graded series of Received December 15, 1996; revised April 16, 1996.
ethanol, and finally embedded in agar 100 epoxy resin. Semithin
sections (1 mm) were stained with touluidine blue for light micros- References
copy, andultrathin sections (60 nm) were contrasted with lead citrate
and examined using a Philips electron microscope. Adamson, I.Y., and King, G.M. (1985). Epithelial-mesenchymal inter-
actions in postnatal rat lung growth. Exp. Lung Res. 8, 261±274.
In Situ Hybridization
Adler, K.B., Low, R.B., Leslie, K.O., Mitchell, J., and Evans, J.N.We have used a nonradioactive protocol for in situ hybridization
(1989). Contractile cells of the normal and fibrotic lung. Lab. Invest.(Henrique et al., 1995). In brief, embryos or dissected tissues were
60, 473±485.fixed in 4% paraformaldehyde overnight and cryoprotected in 30%
Ataliotis, P., Symes, K., Chou, M.M., Ho, L., and Mercola, M. (1995).w/v sucrose in PBS for at least 24 hr. Embryos were frozen in OCT
PDGF signalling is required for gastrulation in Xenopus laevis. Devel-embedding compound (British Drug Houses [BDH]), and blocks
opment 121, 3099±3110.were stored at 2708C overnight or used immediately. Cryosections
(15 mm)were collected on Superfrost Plus slides (BDH). The sections Betsholtz, C. (1995). Role of platelet-derived growth factors in
were air dried and occasionally stored at this stage at 2208C in a mouse development. Int. J. Dev. Biol. 39, 817±825
boxwith silica gel.Sections to be used for hybridization were thawed
Betsholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P.,(if previously stored), treated with 10 mg/ml of proteinase K and
Urdea, M.S., Eddy, R., Shows, T.B., Philpott, K., Mellor, A.L., Knott,0.2% glycine, washed in PBS, and then postfixed in 4% paraformal-
T.J., and Scott, J. (1986). cDNA sequence and chromosomal local-dehyde.
ization of human platelet-derived growth factor A-chain and its ex-PDGF-A probes were generated from a 900 bp EcoRI fragment
pression in tumor cell lines. Nature 320, 695±699.cloned in pGEM-1; the antisense probe was generated by transcrip-
Brody, A.R., and Bonner, J.C. (1991). Platelet-derived growth factortion of an XbaI digest with T7 RNA polymerase and the sense probe
produced by pulmonary cells. Chest 99, 50S±52S.by transcription of a PvuII digest with SP6 RNA polymerase.
PDGFRa probes were generated from a 1.6 kb EcoRI fragment en- Burri, P.H., and Weibel, E.R. (1977). Ultrastructure and morphometry
coding the extracellular domain of the receptor cloned inpBluescript of the developing lung. In Development of theLung, Part 1: Structural
KS; the antisense probe was generated by transcription of a HindIII Development, W.A. Hodson, ed. (New York: Marcel Dekker), pp.
digest with T7 RNA polymerase and the sense probe by transcription 215±268.
of a BamHI digest with T3 RNA polymerase (both PDGF-A and
Damiano, V.V., Tsang, A.-L., Christner, P., Rosenbloom, J., andPDGFRa probes were gifts from W. D. Richardson). Probes were
Weinbaum, G. (1979). Immunological localization of elastin by elec-labeled by incorporation of digoxygenin (DIG)-labeled UTP (leveling
tron microscopy. Am. J. Pathol. 96, 439±448.mix from Boehringer Mannheim).
Duttlinger, R., Manova, K., Berrozpe, G., Chu, T.-Y., DeLeon, V.,For in situ hybridization, sections were prehybridized with hybrid-
Timokhina, I., Chaganti, R.S.K., Zelenetz, A.D., Bachvarova, R.F.,izationsolution (50%formamide, 10% dextran sulfate, 1 mg/ml yeast
and Besmer, P. (1995). The Wsh and Ph mutations affect the c-kittRNA, 13 Denhardt's solution, 5 mM EDTA, 0.2 M NaCl, 0.013 M
expression profile: c-kit misexpression in embryogenesis impairsTris±HCl, 5 mM NaH2PO4, 5 mM Na2HPO4). After denaturation at
melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci.708C for 10 min, the probe was added at a concentration of 2±8 ng/
ml hybridization solution, and the sections were incubated overnight USA 92, 3754±3758.
at 658C. Posthybridization washes were carried out at 658C in 13 Emery, J.L. (1970). The postnatal development of the human lung
SSC, 50% formamide, 0.1% Tween 20, and preantibody washes and its implication for lung pathology. Respiration 27, 41±50.
were done at room temperature with MABT (100 mM maleic acid,
Fukuda, Y., Ferrans, V.J., and Crystal, R.G. (1983). The development150 mM NaCl, 0.1% Tween 20 [pH 7.0]). After blocking in MABT with
of alveolar septa in fetal sheep lung: an ultrastructural and immuno-20% sheep serum (Serotec) and 2% blocking reagent (Boehringer
histochemical study. Am. J. Anat. 167, 405±439.Mannheim), antibody incubation was performed with anti-DIG-alka-
GruÈ neberg, H., and Truslove, G.M. (1960). Two closely linked genesline phosphatase Fab fragments (Boehringer Mannheim) at 1:1000
of the mouse. Genet. Res. 1, 69±90.dilution in blocking solution overnight. Post antibody washes were
with MABT, and prestaining washes were with staining buffer (100 Heldin, C.-H. (1992). Structural and functional studies of platelet-
mM NaCl, 50 mM MgCl2, 100 mM Tris [pH 9.5], 0.1% Tween 20, derived growth factor. EMBO J. 11, 4251±4259.
5 mM Levamisole (Sigma). NBT (4-nitroblue tetrazolium chloride;
Heldin, C.H., OÈ stman, A., and Westermark, B. (1993). Structure of
Boehringer Mannheim) and X-phosphate (5-bromo-4-chloro-3-indo-
platelet-derived growth factor: implications for functional proper-lyl-phosphate; Boehringer Mannheim) were used at final concentra-
ties. Growth Factors 8, 245±252.tions of 8.75 mg/ml and 5.63 mg/ml, respectively, and the alkaline
Henrique, D., Adam, J., Myat, A., Chitnis, A., Lewis, J., and Ish-phosphatase reaction was carried out at room temperature over-
Horowicz, D. (1995). Expression of a d homologue in prospectivenight. Sections were dehydrated and mounted in DPX.
neurons in the chick. Nature 375, 787±790.
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